Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study

Journal of Diabetes and its Complications

Volumn 28, Issue 6, 2014, Pages 850-857

  Henshaw, Frances R ^a,b   Bolton, Thyra ^b   Nube, Vanessa ^b   Hood, Anita ^b   Veldhoen, Danielle ^b   Pfrunder, Louise ^b   McKew, Genevieve L ^a,b   MacLeod, Colin ^a,b   McLennan, Susan V ^a,b   Twigg, Stephen M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Bacteria; Diabetic foot ulcer; MMP 9; Pilot; Propolis

Indexed keywords

GELATINASE A; GELATINASE B; PROPOLIS; PROTECTIVE AGENT; WOUND HEALING PROMOTING AGENT; ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; BEE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEBRIDEMENT; DIABETIC FOOT; DISEASE COURSE; DRUG DETERMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN DEPLETION; ULCER HEALING; WOUND FLUID; AGED; BODY FLUID; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL LOAD; BODY FLUIDS; DIABETIC FOOT; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROPOLIS; PROTECTIVE AGENTS; WOUND HEALING;

EID: 84908300106     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.07.012     Document Type: Article

References (53)

1. American Diabetes Association Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts Diabetes Care 22 1999 1354 1360
2. A. Aparecida Da Silva, E.C. Leal-Junior, A.C. Alves, C.S. Rambo, S.A. Dos Santos, and R.P. Vieira Wound-healing effects of low-level laser therapy in diabetic rats involve the modulation of MMP-2 and MMP-9 and the redistribution of collagen types I and III Journal of Cosmetic and Laser Therapy 15 2013 210 216
3. A. Astani, S. Zimmermann, E. Hassan, J. Reichling, K.H. Sensch, and P. Schnitzler Antimicrobial activity of propolis special extract GH 2002 against multidrug-resistant clinical isolates Pharmazie 68 2013 695 701
4. V.S. Bankova, S.L. De Castro, and M.C. Marcucci Propolis: Recent advances in chemistry and plant origin Apidologie 31 2000 3 15
5. A.H. Banskota, T. Nagaoka, L.Y. Sumioka, Y. Tezuka, S. Awale, and K. Midorikawa Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines Journal of Ethnopharmacology 80 2002 67 73
6. J. Bentley, and A. Foster Multidisciplinary management of the diabetic foot ulcer British Journal of Community Nursing 12 2007 S6 S10
7. J.S. Bonvehi, and F.V. Coll The composition, active components and bacteriostatic activity of propolis in dietetics Journal of the American Oil Chemists Society 71 1994 529 532
8. A.J. Boulton, L. Vileikyte, G. Ragnarson-Tennvall, and J. Apelqvist The global burden of diabetic foot disease The Lancet 366 2005 1719 1724
9. M.C. Bufalo, I. Ferreira, G. Costa, V. Francisco, J. Liberal, and M.T. Cruz Propolis and its constituent caffeic acid suppress LPS-stimulated pro-inflammatory response by blocking NF-kappaB and MAPK activation in macrophages Journal of Ethnopharmacology 149 2013 84 92
10. P.R. Cavanagh, B.A. Lipsky, A.W. Bradbury, and G. Botek Treatment for diabetic foot ulcers Lancet 366 2005 1725 1735
11. L. Drago, B. Mombelli, E. De Vecchi, M.C. Fassina, L. Tocalli, and M.R. Gismondo In vitro antimicrobial activity of propolis dry extract Journal of Chemotherapy 12 2000 390 395
12. O. Erkmen, and M.M. Ozcan Antimicrobial effects of Turkish propolis, pollen, and laurel on spoilage and pathogenic food-related microorganisms Journal of Medicinal Food 11 2008 587 592
13. V. Falanga Wound healing and its impairment in the diabetic foot Lancet 366 2005 1736 1743
14. A.P. Farnesi, R. Aquino-Ferreira, D. De Jong, J.K. Bastos, and A.E. Soares Effects of stingless bee and honey bee propolis on four species of bacteria Genetics and Molecular Research 8 2009 635 640
15. Y.M. Fonseca, F. Marquele-Oliveira, F.T. Vicentini, N.A. Furtado, J.P. Sousa, and Y.M. Lucisano-Valim Evaluation of the potential of Brazilian propolis against UV-induced oxidative stress Evidence-based Complementary and Alternative Medicine 2011 10.1155/2011/863917
16. E. Gallo, E. Lucenteforte, F. Firenzuoli, F. Menniti-Ippolito, V. Maggini, and A. Pugi Herbalists' perception of risks involving commonly sold medicinal plants in Italy Complementary Therapies in Medicine 22 2014 81 86
17. G. Gekker, S. Hu, M. Spivak, J.R. Lokensgard, and P.K. Peterson Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures Journal of Ethnopharmacology 102 2005 158 163
18. D. Grunberger, R. Banerjee, K. Eisinger, E.M. Oltz, L. Efros, and M. Caldwell Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis Experientia 44 1988 230 232
19. U.H. Jin, T.W. Chung, S.K. Kang, S.J. Suh, J.K. Kim, and K.H. Chung Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: Isolation and identification Clinica Chimica Acta 362 2005 57 64
20. I. Kosalec, S. Pepeljnjak, M. Bakmaz, and S. Vladimir-Knezevic Flavonoid analysis and antimicrobial activity of commercially available propolis products Acta Pharmaceutica 55 2005 423 430
21. G.P. Ladwig, M.C. Robson, R. Liu, M.A. Kuhn, D.F. Muir, and G.S. Schultz Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers Wound Repair and Regeneration 10 2002 26 37
22. R. Liu, L. Li, M. Yang, G. Boden, and G. Yang Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers Mayo Clinic Proceedings 88 2013 166 175
23. Y. Liu, D. Min, T. Bolton, V. Nubé, S.M. Twigg, and D.K. Yue Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers Diabetes Care 32 2009 117 119
24. M. Lotfy, G. Badra, W. Burham, and F.Q. Alenzi Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus British Journal of Biomedical Science 63 2006 171 173
25. S.V. McLennan, J. Bonner, S. Milne, L. Lo, A. Charlton, and S. Kurup The anti-inflammatory agent propolis improves wound healing in a rodent model of experimental diabetes Wound Repair and Regeneration 16 2008 706 713
26. J. Metzner, E.M. Schneidewind, and E. Friedrich Effect of propolis and pinocembrin on fungi Pharmazie 32 1977 730
27. C.M. Mihai, L.A. Marghitas, D.S. Dezmirean, F. Chirila, R.F. Moritz, and H. Schluns Interactions among flavonoids of propolis affect antibacterial activity against the honeybee pathogen Paenibacillus larvae Journal of Invertebrate Pathology 110 2012 68 72
28. O.K. Mirzoeva, R.N. Grishanin, and P.C. Calder Antimicrobial action of propolis and some of its components: The effects on growth, membrane potential and motility of bacteria Microbiological Research 152 1997 239 246
29. M.G. Morales, C. Cabello-Verrugio, C. Santander, D. Cabrera, R. Goldschmeding, and E. Brandan CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy Journal of Pathology 225 2011 490 501
30. T. Nagaoka, A.H. Banskota, Y. Tezuka, K. Midorikawa, K. Matsushige, and S. Kadota Caffeic acid phenethyl ester (CAPE) analogues: Potent nitric oxide inhibitors from the Netherlands propolis Biological and Pharmaceutical Bulletin 26 2003 487 491
31. K. Natarajan, S. Singh, T.R. Burke Jr., D. Grunberger, and B.B. Aggarwal Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B Proceedings of the National Academy of Sciences of the United States of America 93 1996 9090 9095
32. S.O. Oyibo, E.B. Jude, I. Tarawneh, H.C. Nguyen, L.B. Harkless, and A.J. Boulton A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems Diabetes Care 24 2001 84 88
33. S. Pepeljnjak, and I. Kosalec Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa FEMS Microbiology Letters 240 2004 111 116
34. L. Pradhan, X. Cai, S. Wu, N.D. Andersen, M. Martin, and J. Malek Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing Journal of Surgical Research 167 2011 336 342
35. L. Prompers, N. Schaper, J. Apelqvist, M. Edmonds, E.B. Jude, and D. Mauricio Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study Diabetologia 51 2008 747 755
36. S. Rajpara, M.S. Wilkinson, C.M. King, D.J. Gawkrodger, J.S. English, and B.N. Statham The importance of propolis in patch testing - A multicentre survey Contact Dermatitis 61 2009 287 290
37. J.L. Richard, J. Martini, M.M. Bonello Faraill, J.M. Bemba, M. Lepeut, and F. Truchetet Management of diabetic foot ulcers with a TLC-NOSF wound dressing Journal of Wound Care 21 2012 142 147
38. A. Russo, R. Longo, and A. Vanella Antioxidant activity of propolis: Role of caffeic acid phenethyl ester and galangin Fitoterapia 73 Suppl. 1 2002 S21 S29
39. S. Scheller, J. Tustanowski, B. Kurylo, Z. Paradowski, and Z. Obuszko Biological properties and clinical application of propolis. III. Investigation of the sensitivity of Staphylococci isolated from pathological cases to ethanol extract of propolis (EEP). Attempts on inducing resistance in laboratory Staphylococcus strain to EEP Arzneimittel-Forschung 27 1977 1395
40. J.A. Schwartz, JCn Lantis, C. Gendics, A.M. Fuller, W. Payne, and D. Ochs A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers International Wound Journal 10 2013 193 199
41. J.M. Sforcin, and V. Bankova Propolis: Is there a potential for the development of new drugs? Journal of Ethnopharmacology 133 2011 253 260
42. J. Shaw, C.M. Hughes, K.M. Lagan, and P.M. Bell The clinical effect of topical phenytoin on wound healing: A systematic review British Journal of Dermatology 157 2007 997 1004
43. J. Shaw, C.M. Hughes, K.M. Lagan, M.R. Stevenson, C.R. Irwin, and P.M. Bell The effect of topical phenytoin on healing in diabetic foot ulcers: A randomized controlled trial Diabetic Medicine 28 2011 1154 1157
44. A. Shearer, P. Scuffham, A. Gordois, A. Oglesby, and J.A. Tobian The health care costs of diabetic peripheral neuropathy in the US Diabetes Care 26 2003 1790 1795
45. P. Sheehan, P. Jones, J.M. Giurini, A. Caselli, and A. Veves Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial Plastic and Reconstructive Surgery 17 2006 239S 244S
46. W.K. Stadelmann, and A.G. Digenis Physiology and healing dynamics of chronic cutaneous wounds American Journal of Surgery 176 1998 26S 38S
47. F.M. Suk, C.H. Chen, S.Y. Lin, C.J. Cheng, S.J. Yen, and L.F. Hung 15-Deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells Toxicology Letters 187 2009 22 27
48. Z.S. Talas, I. Ozdemir, O. Ciftci, O. Cakir, M.F. Gulhan, and O.M. Pasaoglu Role of propolis on biochemical parameters in kidney and heart tissues against l-NAME induced oxidative injury in rats Clinical and Experimental Hypertension 2014 [Ahead of print; PMID: 24490594]
49. V.D. Wagh Propolis: A wonder bees product and its pharmacological potentials Advances in Pharmacological Sciences 2013 10.1155/2013/308249
50. V.D. Wagh Propolis: A wonder bees product and its pharmacological potentials Advances in Pharmacological Sciences 2013 2013 308249
51. R.D. Wojtyczka, A. Dziedzic, D. Idzik, M. Kepa, R. Kubina, and A. Kabala-Dzik Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs Molecules 18 2013 9623 9640
52. J.S. Wrobel, J.A. Mayfield, and R. GE Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population Diabetes Care 24 2005 860 864
53. L. Xu, S.V. McLennan, L. Lo, A. Natfaji, T. Bolton, and Y. Liu Bacterial load predicts healing rate in neuropathic diabetic foot ulcers Diabetes Care 30 2007 378 380